Expired
Lead Plaintiff Deadline
Mar 19, 2024
Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that AlloVir, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the posoleucel Phase 3 Studies were unlikely to meet their primary endpoints; (ii) as a result, it was likely that the Company would ultimately discontinue the posoleucel Phase 3 studies; (iii) accordingly, AlloVir overstated the efficacy and clinical and/or commercial prospects of posoleucel; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
In order to be eligible to join the ALVR class action lawsuit, you must have incurred a loss on shares of AlloVir purchased during the class period listed above.
If you suffered a loss in AlloVir during the relevant time frame or pursuant to the relevant offering(s), you have until March 19, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
